HOMA-IR is a score worked out from two fasting blood results, glucose and insulin, and it estimates how hard your body is working to keep blood sugar steady. A higher score means you're making more insulin to do the same job, which is the early pattern of insulin resistance. That can build for years while your glucose still looks normal. The lab range runs from 0.6 to 2.9, but we like to see a score of 1.0 or below. HOMA-IR is calculated for you in the Vively Baseline Health Check, part of the $99 a month membership, and it sits in the app next to your glucose and insulin. Want to work out your own score? Use our HOMA-IR calculator.
Check HOMA-IR alongside 70+ other markers in Vively's Baseline Health Check.
Every marker in range? Get your money back. T&Cs apply.HOMA-IR, or the Homeostatic Model Assessment of Insulin Resistance, is a calculated index used to estimate how sensitive or resistant your body is to insulin. It is not measured directly. Instead, it is worked out from two fasting blood test results: fasting glucose and fasting insulin. The formula, developed by Matthews and colleagues at Oxford in 1985, multiplies the two values and divides by a constant.
Because HOMA-IR combines both sides of the glucose-insulin relationship, it often reveals insulin resistance earlier than fasting glucose or HbA1c alone. A single result is a snapshot, but tracked over time it becomes a valuable indicator of metabolic health. You can read more about the individual components in our fasting insulin guide.
Dr Michelle Woolhouse, Vively Medical Director, explains what a HOMA-IR result means, why Vively aims for 1.0 or below, why insulin resistance matters, and which markers to check alongside it.
General information, not medical advice. Talk to your doctor about your own results.
Insulin resistance is the shared root of many of the biggest chronic disease risks, including type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease, PCOS, dementia and some cancers. HOMA-IR captures this dysfunction early, often years before fasting glucose or HbA1c drift out of range. In practice, that means it can flag risk while lifestyle changes are still highly effective.
Beyond disease risk, insulin resistance affects energy, weight, appetite, hormonal balance, sleep and recovery from exercise. Understanding your HOMA-IR gives you a way to see how well your metabolism is functioning under the surface, not just how you feel day to day. It is one of the calculated indexes Vively includes as part of its baseline health testing.
Vively optimal score: 1.0 or below. This is the score we aim for to support long-term metabolic health. It is a goal to work towards and is not used to diagnose any condition.
Commonly quoted reference range: 0.6 to 2.9. HOMA-IR has no unit, and most lab reports don’t print it, so you may need to work it out from your fasting glucose and fasting insulin with our HOMA-IR calculator.
Normal does not always mean optimal. Insulin resistance can build for 10 to 15 years before glucose becomes abnormal, so a score inside the reference range can still be a sign of early metabolic strain. Broadly, a score below 1.0 points to good insulin sensitivity, 1.0 to 1.9 is a middle zone, around 2.0 upward suggests emerging insulin resistance, and above 2.9 is usually read as significant insulin resistance. Among Vively members, the median HOMA-IR in every age group was 1.3 to 1.8, which is inside the reference range and above our optimal score.
Your score is read in context, alongside your age, sex, ethnicity, body composition, medications, pregnancy status, symptoms and your fasting glucose and insulin results on their own. HOMA-IR is most useful when tracked over time rather than judged from a single test.
Because HOMA-IR is calculated from fasting insulin and fasting glucose, anything that changes either of those markers will move the score. The biggest drivers are diet quality (especially intake of refined carbohydrates, sugary drinks and ultra-processed foods), body composition (particularly visceral fat), physical activity levels and muscle mass, sleep quality, chronic stress and alcohol intake.
Hormonal changes across life stages, including puberty, pregnancy, PCOS, perimenopause and menopause, can shift insulin sensitivity. Medications such as corticosteroids, some antipsychotics, certain diuretics and hormonal contraceptives can also affect HOMA-IR. Illness, inflammation, poor sleep and even a bad week of stress can nudge the number, which is one reason patterns matter more than single readings.
A high HOMA-IR often has no obvious symptoms, which is one of the main reasons insulin resistance can go undetected for years. When symptoms do appear, they can include stubborn weight gain around the middle, ongoing fatigue, energy crashes after meals, strong sugar or carbohydrate cravings, brain fog, skin tags and dark velvety patches of skin around the neck, armpits or groin.
In women, elevated HOMA-IR is closely tied to PCOS symptoms such as irregular periods, acne and unwanted hair growth. These signs are not diagnostic on their own, but they can be a useful prompt to test. Our guide on how to tell if you are insulin resistant covers this in more detail.
The most common driver is insulin resistance, where cells in muscle, liver and fat become less responsive to insulin, so the pancreas increases output to compensate. Both fasting insulin and, over time, fasting glucose start to climb, and HOMA-IR rises with them. Contributing factors include a diet high in refined carbohydrates and ultra-processed foods, excess visceral fat, sedentary lifestyle, poor sleep, chronic stress, PCOS, non-alcoholic fatty liver disease and genetic predisposition.
Pregnancy naturally increases insulin resistance, particularly in the second and third trimesters. Corticosteroid medications, Cushing's syndrome, chronic inflammation and some other medical conditions can also raise HOMA-IR. A trend of rising HOMA-IR over months or years is often more meaningful than any single number.
In healthy people, a low HOMA-IR alongside normal glucose usually reflects good insulin sensitivity and is generally a positive sign. However, HOMA-IR relies on the pancreas producing insulin, so it becomes less reliable in situations where insulin production is impaired. In late-stage type 2 diabetes, type 1 diabetes or other pancreatic conditions, both fasting insulin and HOMA-IR may look low while blood glucose is high.
HOMA-IR is also not appropriate for people using insulin therapy, since the injected insulin does not reflect pancreatic function. In these situations, other tests are used, and clinical context is essential.
A higher-than-optimal HOMA-IR suggests your body is compensating harder to keep blood glucose in range, and that muscle, liver and fat cells are becoming less responsive to insulin. It does not diagnose diabetes or any single condition, but it can indicate early metabolic strain and may point to insulin resistance, metabolic syndrome, PCOS, fatty liver disease or increased future risk of type 2 diabetes and cardiovascular disease.
A very low HOMA-IR combined with high glucose can suggest reduced pancreatic function and warrants clinical review. As with any calculated marker, patterns over time and the context of your other results matter far more than any single reading.
Yes. A score inside the reference range can still sit above our optimal score of 1.0. HOMA-IR also reflects insulin resistance in the fasted state, but blood glucose and insulin can behave very differently after meals. Some people have a normal HOMA-IR but experience large post-meal glucose spikes and sharp insulin surges, a pattern known as postprandial hyperinsulinaemia. Standard fasting tests miss this entirely.
Recent illness, medications, unusually low food intake before testing, lab-to-lab variation in insulin assays, and short-term stress can also affect the number. This is why HOMA-IR is best interpreted alongside HbA1c, lipids, liver enzymes, inflammation markers and, where relevant, real-world glucose data. Continuous glucose monitoring often reveals early metabolic changes that a single fasting calculation cannot capture, as explored in our article on continuous glucose monitoring for non-diabetics.
Fasting glucose and fasting insulin are the two markers HOMA-IR is built from, so both should always be reviewed individually as well. HbA1c adds a longer-term view of average blood glucose, and together these four give a strong picture of glucose regulation. Lipids, especially triglycerides and HDL cholesterol, help round out cardiometabolic risk, since high triglycerides and low HDL commonly appear alongside insulin resistance.
Other useful companion markers include ALT and GGT for liver health (fatty liver is closely tied to insulin resistance), hs-CRP for low-grade inflammation, uric acid, and in women, androgens such as testosterone, SHBG and free androgen index if PCOS is suspected. Waist circumference and blood pressure are simple but powerful markers of cardiometabolic risk. You can see the full set of markers Vively looks at through our tests page and shop tests page.
HOMA-IR responds well to consistent lifestyle change. That usually means prioritising whole foods, protein at each meal, plenty of vegetables and fibre, while reducing refined carbohydrates, ultra-processed foods and sugary drinks. Regular movement is especially important, with strength training building insulin-sensitive muscle mass, aerobic activity improving glucose uptake, and short post-meal walks helping to blunt post-meal spikes.
Sleep of 7 to 9 hours, stress management, moderating alcohol and reducing visceral fat all improve insulin sensitivity. Not every marker can or should be self-optimised, and progress is often faster and more sustainable when guided by a clinician. Vively's how it works page explains how testing, continuous glucose monitoring and dietitian coaching come together to make change practical.
See your GP if your HOMA-IR is persistently elevated, is trending upward, or is accompanied by symptoms such as unexplained weight change, extreme thirst, frequent urination, recurrent infections, dark patches of skin or ongoing fatigue. A very low HOMA-IR combined with high glucose also warrants prompt review, as it may suggest reduced pancreatic function.
Clinical input is particularly important during pregnancy or when planning pregnancy, with a history of gestational diabetes, PCOS, cardiovascular disease, fatty liver, kidney disease, or when starting or changing medications that affect insulin or glucose. HOMA-IR should never be self-diagnosed, as it is one piece of a bigger clinical picture your GP, endocrinologist or accredited practising dietitian can help you interpret.
HOMA-IR is one of the calculated metabolic scores included in the Vively Baseline Health Check, alongside its component markers fasting glucose and fasting insulin, and other biomarkers such as HbA1c, lipids, liver enzymes, inflammation markers and hormones. Rather than looking at HOMA-IR in isolation, Vively interprets it in context with your other results, symptoms, lifestyle and, where relevant, your real-world glucose data from a continuous glucose monitor.
An accredited practising dietitian reviews your results with you one on one, helping you understand what they mean and what changes may support your health goals. Because your markers are retested over time, you can see how nutrition, movement, sleep and stress are actually shifting insulin sensitivity, not just guessing. Start at the Vively homepage or explore the full range of tests in the Vively shop.
Among 5,346 Vively members tested in 2024 to 2026, women aged 40 to 49 had a median HOMA-IR of 1.3 (middle half 0.9 to 1.9). Men the same age: 1.4. Vively’s optimal HOMA-IR is 1.0 or below. HOMA-IR is calculated from fasting glucose and fasting insulin, so most lab reports don’t show it. The median member in every age group was above it. A member median is not a target.
The line is the median member at each age. The shaded bands show where most members sit. Every median sits above Vively’s optimal of 1.0 or below.
| Group | Members | Median | Middle 50% | 5th to 95th percentile | Vively optimal |
|---|---|---|---|---|---|
| Women 18 to 29 | 228 | 1.5 | 1.0 to 2.1 | 0.6 to 4.1 | 1.0 or below |
| Women 30 to 39 | 868 | 1.4 | 0.9 to 1.9 | 0.6 to 3.8 | 1.0 or below |
| Women 40 to 49 | 1,011 | 1.3 | 0.9 to 1.9 | 0.6 to 4.1 | 1.0 or below |
| Women 50 to 59 | 782 | 1.4 | 0.9 to 2.2 | 0.6 to 4.7 | 1.0 or below |
| Women 60 and over | 437 | 1.6 | 1.1 to 2.7 | 0.6 to 5.7 | 1.0 or below |
| Men 18 to 29 | 216 | 1.3 | 0.8 to 1.8 | 0.4 to 3.6 | 1.0 or below |
| Men 30 to 39 | 572 | 1.3 | 0.9 to 1.8 | 0.5 to 4.0 | 1.0 or below |
| Men 40 to 49 | 623 | 1.4 | 0.9 to 2.2 | 0.5 to 4.9 | 1.0 or below |
| Men 50 to 59 | 371 | 1.6 | 1.0 to 2.7 | 0.6 to 7.0 | 1.0 or below |
| Men 60 and over | 238 | 1.8 | 1.2 to 2.6 | 0.6 to 6.0 | 1.0 or below |
Pick your sex and age, then type your result.
What is a normal HOMA-IR for my age?
Among 5,346 Vively members (first blood test, January 2024 to October 2026), the median HOMA-IR for women was 1.5 at 18 to 29, 1.4 at 30 to 39, 1.3 at 40 to 49, 1.4 at 50 to 59 and 1.6 at 60 and over. For men it was 1.3 at 18 to 29, 1.3 at 30 to 39, 1.4 at 40 to 49, 1.6 at 50 to 59 and 1.8 at 60 and over.
Vively’s optimal HOMA-IR is 1.0 or below. HOMA-IR is calculated from fasting glucose and fasting insulin, so most lab reports don’t show it. The median member in every age group was above it. A member median is not a target or a diagnosis. Talk to your practitioner or GP about your score alongside your fasting glucose and fasting insulin.
How to get it: Included in the Baseline Health Check. A GP from our network signs your request after a short telehealth consult, so you don't need to visit your own GP first. See how a blood test without a referral works. HOMA-IR, which is calculated from fasting insulin, is part of the Baseline for almost all members, subject to the reviewing doctor.
Calculator: HOMA-IR calculator. Work out your score from your fasting glucose and fasting insulin results.
Related tests: Insulin, TyG Index, Haemoglobin A1c (HbA1c) NGSP/DCCT %, Haemoglobin A1c (HbA1c) IFCC mmol/mol
Learn more: Soluble fibre improves glycemic control in diabetes: studies; How soluble fibre regulates blood sugar
Guide: HbA1c levels by age, with Vively member data.
The Baseline Health Check reads 70+ markers, then your dietitian turns your results into a plan. $99$79 this Black Friday, ends 1 Dec. Then $99 a month, cancel anytime.
Every marker in range? Get your money back. T&Cs apply.